Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.40 per share
-
Shares outstanding
-
23.6M
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
22.3M
-
Shares change
-
+9.69M
-
Total reported value, excl. options
-
$128M
-
Value change
-
+$53M
-
Number of buys
-
37
-
Number of sells
-
-14
-
Price
-
$5.73
Significant Holders of Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL) as of Q1 2021
63 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share as of Q1 2021.
Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.3M shares
of 23.6M outstanding shares and own 94.32% of the company stock.
Largest 10 shareholders include Capital World Investors (2.96M shares), Polygon Management Ltd. (2.44M shares), Capital International Investors (2.27M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.14M shares), Opaleye Management Inc. (2.11M shares), FMR LLC (2.07M shares), SCHRODER INVESTMENT MANAGEMENT GROUP (1.67M shares), Ikarian Capital, LLC (1.26M shares), Alphabet Inc. (698K shares), and JPMORGAN CHASE & CO (554K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.